Tag: TIGIT

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to TIGIT

UCF “Beefing Up” Natural Killer Cells to Stop Cancer | University of Central Florida News

Added to Collection on: 2024-01-29 18:51:37

Tags for this article:

Immune system
Immunology
Lymphocytes
TIGIT
T cells
Cancer immunotherapy
Natural killer cell
Immunotherapy
Immunologic Constant of Rejection
Jane Grogan
NK cells
Alicja Copik

Click the tags to see associated articles and topics

View Article Details
Phanes Therapeutics, Inc. Announces Clinical Supply Agreement with Roche to ... - Morningstar

Added to Collection on: 2024-05-08 22:08:55

Tags for this article:

Lung cancer
Infectious causes of cancer
Orphan drugs
Cancer immunotherapy
Atezolizumab
Small-cell carcinoma
Checkpoint inhibitor
Bispecific monoclonal antibody
Roche
Neuroendocrine tumor
Treatment of lung cancer
TIGIT
Phanes Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
AstraZeneca sets lofty target of $80bn in revenues by 2030 - Pharmaphorum

Added to Collection on: 2024-05-21 16:57:26

Tags for this article:

Immunology
AstraZeneca
Medical research
Södertälje Municipality
Pascal Soriot
Bispecific monoclonal antibody
Antibody-drug conjugate
Deruxtecan
TIGIT
Greenhouse gas emissions
Antibody
Pfizer
Soriot

Click the tags to see associated articles and topics

View Article Details
CDSCO Panel Rejects Roche Products India local Phase III CT waiver proposal for ...

Added to Collection on: 2024-06-18 15:59:33

Tags for this article:

Orphan drugs
Atezolizumab
Injection
Subcutaneous administration
Cancer immunotherapy
TIGIT
Roche Products
India

Click the tags to see associated articles and topics

View Article Details
Merck stops testing combo drug for lung cancer | The Mighty 790 KFGO

Added to Collection on: 2024-08-08 17:04:40

Tags for this article:

Cancer immunotherapy
Virotherapy
Antineoplastic drugs
Orphan drugs
TIGIT
Lung cancer
Immunotherapy
Pembrolizumab
Small-cell carcinoma
Checkpoint inhibitor
Merck

Click the tags to see associated articles and topics

View Article Details
Long-Term KEYNOTE-006 Data Support Pembrolizumab as SOC in Advanced Melanoma

Added to Collection on: 2024-09-15 17:12:08

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Ipilimumab
Melanoma
Merck & Co.
Progression-free survival
Uveal melanoma
MRNA-4157/V940
TIGIT
Caroline Robert

Click the tags to see associated articles and topics

View Article Details
Roche immunotherapy fails in lung cancer study, raising questions about drug's target - STAT News

Added to Collection on: 2024-11-27 21:28:13

Tags for this article:

TIGIT
Orphan drugs
Atezolizumab
Immune system
Clusters of differentiation
Health effects of tobacco
Small-cell carcinoma
Roche
Lung cancer
Programmed cell death protein 1
Cancer immunotherapy
Cancer

Click the tags to see associated articles and topics

View Article Details
Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ...

Added to Collection on: 2025-01-06 19:47:42

Tags for this article:

Hepatology
Orphan drugs
Hepatocellular carcinoma
Angiogenesis inhibitors
Atezolizumab
Liver cancer
Bevacizumab
T-box transcription factor T
TIGIT
Bland embolization
Tempest Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Tiragolumab addition may boost first-line liver cancer response | springermedicine.com

Added to Collection on: 2025-01-31 11:19:28

Tags for this article:

Orphan drugs
TIGIT
Atezolizumab
Bevacizumab
Hepatocellular carcinoma
Treatment of lung cancer
Evofosfamide

Click the tags to see associated articles and topics

View Article Details
Cabometyx Combo Maintains Progression-Free Survival Benefit in Advanced RCC

Added to Collection on: 2025-02-15 21:10:47

Tags for this article:

Orphan drugs
Antineoplastic drugs
Renal cell carcinoma
Cabozantinib
Nivolumab
Ipilimumab
Progression-free survival
Wee1
TIGIT
Checkpoint inhibitor
Yervoy

Click the tags to see associated articles and topics

View Article Details